CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer

Abstract Background Chemoresistance and immunosuppression are two major obstacles in the current anti-cancer treatments. This study investigates the involvements of a CCAAT enhancer binding protein delta (CEBPD)/vesicle associated membrane protein 3 (VAMP3) axis in paclitaxel (PTX) resistance and im...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yan Zhao, Yangyang Yu, Xiangmin Li, Ayao Guo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2024-04-01
Serie:	Journal of Experimental & Clinical Cancer Research
Soggetti:	CEBPD VAMP3 Triple-negative breast cancer Autophagy Paclitaxel resistance Immune evasion
Accesso online:	https://doi.org/10.1186/s13046-024-03041-8
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!